Na/K-transporting ATPase sub. α-3
AltitudeomicsDB
Protein Official symbol |
ATP1A3 |
Aliases |
ATP1A3 |
Chromosomal Location |
19 |
Length |
1013 |
Uniprot ID |
P13637 |
EC number |
7.2.2.13 |
Protein family Information(Pfam) |
PF00689;PF00690; |
PDB id |
None |
InterPro ID |
IPR006068;IPR004014;IPR023299;IPR018303;IPR023298;IPR008250;IPR036412;IPR023214;IPR005775;IPR001757; |
dbSNP |
rs542652468 rs542652468 rs606231427 rs1396898460 rs80356532 rs80356532 rs80356533 rs879255368 rs606231428 rs606231430 rs606231433 rs80356534 rs557052809 rs557052809 rs80356535 rs534926223 rs606231437 rs606231437 rs80356536 rs80356537 rs80356537 rs549006436 rs536681257 rs387907282 rs387907281 rs587777771 rs267606670 rs267606670 rs606231444 rs398122887 rs606231446 rs606231447 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
ATP1A3 |
ATP1B3 |
0.9940000000000001 |
ATP1A3 |
ATP1B1 |
0.99 |
ATP1B1 |
FXYD2 |
0.9890000000000001 |
ATP1B1 |
FXYD7 |
0.983 |
ATP1A3 |
ATP1B2 |
0.978 |
FXYD2 |
ATP1B3 |
0.975 |
ATP1A3 |
FXYD2 |
0.97 |
FXYD2 |
ATP1B2 |
0.9670000000000001 |
FXYD2 |
ATP1B4 |
0.9540000000000001 |
ATP1A3 |
ATP1B4 |
0.9390000000000001 |
ATP1A3 |
FXYD7 |
0.937 |
FXYD6 |
ATP1A3 |
0.9309999999999999 |
FXYD6 |
ATP1B2 |
0.9309999999999999 |
FXYD1 |
ATP1B1 |
0.9309999999999999 |
ATP1A3 |
RS1 |
0.924 |
FXYD3 |
ATP1B1 |
0.924 |
FXYD3 |
ATP1B2 |
0.9229999999999999 |
FXYD7 |
ATP1B2 |
0.922 |
FXYD6 |
ATP1B3 |
0.9209999999999999 |
FXYD3 |
ATP1B3 |
0.92 |
FXYD4 |
ATP1B1 |
0.915 |
FXYD1 |
ATP1A3 |
0.914 |
ATP1B1 |
ATP1B2 |
0.914 |
FXYD1 |
ATP1B2 |
0.9129999999999999 |
RS1 |
ATP1B2 |
0.9129999999999999 |
FXYD4 |
ATP1B2 |
0.912 |
FXYD3 |
ATP1A3 |
0.912 |
FXYD6 |
ATP1B1 |
0.912 |
ATP1B1 |
ATP1B3 |
0.9109999999999999 |
FXYD4 |
ATP1A3 |
0.9109999999999999 |
FXYD4 |
ATP1B3 |
0.91 |
FXYD1 |
ATP1B3 |
0.909 |
ATP1B3 |
FXYD7 |
0.9059999999999999 |
ATP1B3 |
ATP1B2 |
0.9059999999999999 |
ATP1A3 |
AGRN |
0.905 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
478 (ATP1A3) |
481 (ATP1B1) |
486 (FXYD2) |
53826 (FXYD6) |
5348 (FXYD1) |
5349 (FXYD3) |
53822 (FXYD7) |
53828 (FXYD4) |
6247 (RS1) |
483 (ATP1B3) |
482 (ATP1B2) |
23439 (ATP1B4) |
375790 (AGRN) |
478 (ATP1A3)
|
1.00
|
0.60
|
0.43
|
0.40
|
0.33
|
0.17
|
0.39
|
0.17
|
0.39
|
0.51
|
0.60
|
0.46
|
0.42
|
481 (ATP1B1)
|
0.60
|
1.00
|
0.37
|
0.46
|
0.37
|
0.27
|
0.44
|
0.27
|
0.48
|
0.64
|
0.73
|
0.46
|
0.50
|
486 (FXYD2)
|
0.43
|
0.37
|
1.00
|
0.62
|
0.52
|
1.00
|
0.55
|
1.00
|
0.28
|
0.50
|
0.49
|
0.46
|
0.22
|
53826 (FXYD6)
|
0.40
|
0.46
|
0.62
|
1.00
|
0.80
|
1.00
|
0.90
|
1.00
|
0.48
|
0.39
|
0.54
|
0.22
|
0.54
|
5348 (FXYD1)
|
0.33
|
0.37
|
0.52
|
0.80
|
1.00
|
1.00
|
0.91
|
1.00
|
0.39
|
0.34
|
0.46
|
0.10
|
0.43
|
5349 (FXYD3)
|
0.17
|
0.27
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
0.17
|
0.27
|
0.27
|
0.10
|
0.21
|
53822 (FXYD7)
|
0.39
|
0.44
|
0.55
|
0.90
|
0.91
|
1.00
|
1.00
|
1.00
|
0.48
|
0.39
|
0.55
|
0.12
|
0.52
|
53828 (FXYD4)
|
0.17
|
0.27
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
0.17
|
0.27
|
0.27
|
0.10
|
0.21
|
6247 (RS1)
|
0.39
|
0.48
|
0.28
|
0.48
|
0.39
|
0.17
|
0.48
|
0.17
|
1.00
|
0.33
|
0.48
|
0.10
|
0.48
|
483 (ATP1B3)
|
0.51
|
0.64
|
0.50
|
0.39
|
0.34
|
0.27
|
0.39
|
0.27
|
0.33
|
1.00
|
0.96
|
0.46
|
0.33
|
482 (ATP1B2)
|
0.60
|
0.73
|
0.49
|
0.54
|
0.46
|
0.27
|
0.55
|
0.27
|
0.48
|
0.96
|
1.00
|
0.46
|
0.49
|
23439 (ATP1B4)
|
0.46
|
0.46
|
0.46
|
0.22
|
0.10
|
0.10
|
0.12
|
0.10
|
0.10
|
0.46
|
0.46
|
1.00
|
0.12
|
375790 (AGRN)
|
0.42
|
0.50
|
0.22
|
0.54
|
0.43
|
0.21
|
0.52
|
0.21
|
0.48
|
0.33
|
0.49
|
0.12
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
ATP1A3 |
Rat |
Left brain cortices |
300hPa |
9144 m |
1 hour |
downregulated |
0.61±0.1 |
TMT labeled LTQ orbitrap |
Southwestern europe |
Male wistar rats |
1 |
Adult male Wistar rats weighing 350 g |
28697276 |
Association with TF
TF |
TF Entrez |
Gene |
Gene Entrez |
Type |
PMID |
Database |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
478 |
GO:0005524 |
ATP binding |
GOTERM_MF_DIRECT |
478 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
478 |
GO:0030007 |
cellular potassium ion homeostasis |
GOTERM_BP_DIRECT |
478 |
GO:0060048 |
cardiac muscle contraction |
GOTERM_BP_DIRECT |
478 |
GO:0016021 |
integral component of membrane |
GOTERM_CC_DIRECT |
478 |
GO:0086064 |
cell communication by electrical coupling involved in cardiac conduction |
GOTERM_BP_DIRECT |
478 |
GO:0046872 |
metal ion binding |
GOTERM_MF_DIRECT |
478 |
GO:0005783 |
endoplasmic reticulum |
GOTERM_CC_DIRECT |
478 |
GO:0005886 |
plasma membrane |
GOTERM_CC_DIRECT |
478 |
GO:1990239 |
histone methyltransferase binding |
GOTERM_MF_DIRECT |
478 |
GO:0071383 |
cellular response to steroid hormone stimulus |
GOTERM_BP_DIRECT |
478 |
GO:0005794 |
Golgi apparatus |
GOTERM_CC_DIRECT |
478 |
GO:0005890 |
sodium:potassium-exchanging ATPase complex |
GOTERM_CC_DIRECT |
478 |
GO:0007613 |
memory |
GOTERM_BP_DIRECT |
478 |
GO:0036376 |
sodium ion export from cell |
GOTERM_BP_DIRECT |
478 |
GO:1903779 |
regulation of cardiac conduction |
GOTERM_BP_DIRECT |
478 |
GO:0008542 |
visual learning |
GOTERM_BP_DIRECT |
478 |
GO:1903416 |
response to glycoside |
GOTERM_BP_DIRECT |
478 |
GO:0043395 |
glutathione binding |
GOTERM_MF_DIRECT |
478 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway |
GOTERM_BP_DIRECT |
478 |
GO:0030424 |
axon |
GOTERM_CC_DIRECT |
478 |
GO:0000166 |
nucleotide binding |
GOTERM_MF_DIRECT |
478 |
GO:0051087 |
unfolded protein binding |
GOTERM_MF_DIRECT |
478 |
GO:0008344 |
adult locomotory behavior |
GOTERM_BP_DIRECT |
478 |
GO:0010107 |
potassium ion import |
GOTERM_BP_DIRECT |
478 |
GO:0042493 |
response to drug |
GOTERM_BP_DIRECT |
478 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential |
GOTERM_BP_DIRECT |
478 |
GO:0031748 |
haptoglobin binding |
GOTERM_MF_DIRECT |
478 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient |
GOTERM_BP_DIRECT |
478 |
GO:0015991 |
ATP hydrolysis coupled proton transport |
GOTERM_BP_DIRECT |
478 |
GO:0005391 |
sodium:potassium-exchanging ATPase activity |
GOTERM_MF_DIRECT |
478 |
GO:0086037 |
protein phosphatase activator activity |
GOTERM_MF_DIRECT |
478 |
GO:0006883 |
cellular sodium ion homeostasis |
GOTERM_BP_DIRECT |
478 |
GO:0034220 |
ion transmembrane transport |
GOTERM_BP_DIRECT |
478 |
GO:0042383 |
sarcolemma |
GOTERM_CC_DIRECT |
478 |
GO:0044326 |
dendritic spine neck |
GOTERM_CC_DIRECT |
478 |
GO:1903561 |
extracellular vesicle |
GOTERM_CC_DIRECT |
478 |
GO:0044327 |
dendritic spine head |
GOTERM_CC_DIRECT |
478 |
GO:0045202 |
synapse |
GOTERM_CC_DIRECT |
478 |
GO:0043209 |
myelin sheath |
GOTERM_CC_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
478 |
hsa04024 |
cAMP signaling pathway |
478 |
hsa04022 |
cGMP-PKG signaling pathway |
478 |
hsa04261 |
Adrenergic signaling in cardiomyocytes |
478 |
hsa04260 |
Cardiac muscle contraction |
478 |
hsa04960 |
Aldosterone-regulated sodium reabsorption |
478 |
hsa04961 |
Endocrine and other factor-regulated calcium reabsorption |
478 |
hsa04911 |
Insulin secretion |
478 |
hsa04971 |
Gastric acid secretion |
478 |
hsa04919 |
Thyroid hormone signaling pathway |
478 |
hsa04918 |
Thyroid hormone synthesis |
478 |
hsa04978 |
Mineral absorption |
478 |
hsa04974 |
Protein digestion and absorption |
478 |
hsa04964 |
Proximal tubule bicarbonate reclamation |
478 |
hsa04972 |
Pancreatic secretion |
478 |
hsa04970 |
Salivary secretion |
478 |
hsa04973 |
Carbohydrate digestion and absorption |
478 |
hsa04976 |
Bile secretion |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
ATP1A3 |
478 |
Heart Decompensation |
C1961112 |
Pathologic Function |
0.3 |
0.58 |
0.379 |
phenotype |
ATP1A3 |
478 |
Heart Failure, Right-Sided |
C0235527 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Dystonia, Paroxysmal |
C0393588 |
Sign or Symptom |
0.3 |
0.58 |
0.379 |
phenotype |
ATP1A3 |
478 |
Osteoarthrosis Deformans |
C0086743 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Dystonia, Diurnal |
C0393610 |
Sign or Symptom |
0.3 |
0.58 |
0.379 |
phenotype |
ATP1A3 |
478 |
Autosomal Dominant Juvenile Parkinson Disease |
C0752097 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Parkinsonism, Experimental |
C0752101 |
Experimental Model of Disease |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Parkinsonian Disorders |
C0242422 |
Disease or Syndrome |
0.47 |
0.58 |
0.379 |
group |
ATP1A3 |
478 |
Congestive heart failure |
C0018802 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Left-Sided Heart Failure |
C0023212 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Autosomal Recessive Parkinsonism |
C0752100 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Parkinsonism, Juvenile |
C0752105 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Degenerative polyarthritis |
C0029408 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Dystonia, Limb |
C0751093 |
Sign or Symptom |
0.3 |
0.58 |
0.379 |
phenotype |
ATP1A3 |
478 |
Ventricular Dysfunction, Left |
C0242698 |
Pathologic Function |
0.3 |
0.58 |
0.379 |
phenotype |
ATP1A3 |
478 |
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE |
C1868675 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Heart failure |
C0018801 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Familial Juvenile Parkinsonism |
C0752104 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Ramsay Hunt Paralysis Syndrome |
C0242423 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Myocardial Failure |
C1959583 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Dystonia |
C0013421 |
Sign or Symptom |
0.5 |
0.58 |
0.379 |
phenotype |
ATP1A3 |
478 |
Autosomal Dominant Parkinsonism |
C0752098 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Alternating hemiplegia of childhood |
C0338488 |
Disease or Syndrome |
0.6 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
DYSTONIA 12 |
C1868681 |
Disease or Syndrome |
0.8 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
CAPOS syndrome |
C1832466 |
Disease or Syndrome |
0.76 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Parkinson Disease |
C0030567 |
Disease or Syndrome |
0.32 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Epileptic encephalopathy |
C0543888 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Intellectual Disability |
C3714756 |
Mental or Behavioral Dysfunction |
0.4 |
0.58 |
0.379 |
group |
ATP1A3 |
478 |
Ataxias, Hereditary |
C0004138 |
Disease or Syndrome |
0.3 |
0.58 |
0.379 |
group |
ATP1A3 |
478 |
Bipolar Disorder |
C0005586 |
Mental or Behavioral Dysfunction |
0.51 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Mental Depression |
C0011570 |
Mental or Behavioral Dysfunction |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Anhedonia |
C0178417 |
Mental or Behavioral Dysfunction |
0.3 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
Depressive disorder |
C0011581 |
Mental or Behavioral Dysfunction |
0.4 |
0.58 |
0.379 |
disease |
ATP1A3 |
478 |
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2 |
C3553788 |
Disease or Syndrome |
0.41 |
0.58 |
0.379 |
disease |